The subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has already approved the restricted use of Covaxin in emergency situations.
DCGI is the country’s apex regulatory authority for medicinal products.The Drugs Controller General of India (DCGI) is expected to make some big announcements on the COVID-19 vaccine – Covaxin and Covishield. The subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has already approved the restricted use of Covaxin in emergency situations. Covaxin is being indigenously developed by Bharat Biotech.
The panel has also cleared the emergency use authorisation application of the Serum Institute of India (SII). Pune-based SII has is developing Covishield in collaboration with AstraZeneca.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.